Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-789
Closed -$41K 211
2019
Q4
$41K Buy
789
+8
+1% +$398 0.01% 361
2019
Q3
$39K Buy
781
+10
+1% +$492 0.01% 369
2019
Q2
$37K Hold
771
0.01% 387
2019
Q1
$37K Hold
771
﹤0.01% 377
2018
Q4
$32K Sell
771
-11
-1% -$451 0.01% 378
2018
Q3
$32K Buy
782
+27
+4% +$1.09K 0.01% 412
2018
Q2
$30K Buy
755
+104
+16% +$4K 0.01% 416
2018
Q1
$24K Sell
651
-261
-29% -$10.5K ﹤0.01% 422
2017
Q4
$39K Buy
912
+244
+37% +$9.73K 0.01% 399
2017
Q3
$25K Buy
668
+42
+7% +$1.7K ﹤0.01% 397
2017
Q2
$28K Sell
626
-447
-42% -$19.7K ﹤0.01% 364
2017
Q1
$46K Buy
1,073
+7
+0.7% +$285 0.01% 375
2016
Q4
$43K Buy
1,066
+158
+17% +$6.1K 0.01% 388
2016
Q3
$35K Sell
908
-11
-1% -$415 ﹤0.01% 461
2016
Q2
$32K Buy
+919
New +$31.8K ﹤0.01% 490

Other funds holding HOLX

Guardian Life Insurance's HOLX Position: Q1 2020 in Review

Guardian Life Insurance sold out of Hologic (HOLX) in Q1 2020, closing a stake of 789 shares — an estimated $41K sold.

Guardian Life Insurance first reported a position in HOLX in Q2 2016 and held it in 15 quarters. The position peaked at $46K in Q1 2017. 485 funds tracked by Wall St. Rank hold HOLX as of Q1 2020.

  • Guardian Life Insurance reported no remaining Hologic position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 789 Hologic shares in Q1 2020, an estimated $41K.
  • Guardian Life Insurance first reported a position in Hologic in Q2 2016 and held it in 15 quarters.
  • Guardian Life Insurance's Hologic position peaked at $46K in Q1 2017.
  • 485 funds tracked by Wall St. Rank held Hologic as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.